Christ, I think you could make a strong argument that Travelan, if the active ingredients are indeed effective as a Shigella vaccine, is worth $200-$300 million by itself. I posted on here a day or two ago a company that one of the Big Pharmas purchased for $215 million two years ago for a promising Phase 1 Shigella vaccine. That's literally all the company had.
* GSK was the buyer
Big Pharma Partnership, page-5
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.004(4.17%) |
Mkt cap ! $22.79M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $21.54K | 211.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 209410 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 110313 | 7 |
View Market Depth
| Last trade - 14.59pm 16/08/2024 (20 minute delay) ? |
| IMC (ASX) Chart |